The American Academy of Pediatrics (AAP) published an updated clinical practice guideline in Pediatrics entitled, "Management of Hyperbilirubinemia in the Newborn
Infant 35 or More Weeks of Gestation".
These new guidelines entitled: "Management of Hyperbilirubinemia in the Newborn
Infant 35 or More Weeks of Gestation" supersedes earlier guidelines published in 1994.
For monitoring hyperbilirubinemia in the newborn
, methods are desirable that provide fast but reliable results from very small volumes of whole blood, enabling bilirubin measurements at the point of care.
Treatment of unconjugated hyperbilirubinemia in the newborn
is based on history, clinical course, and physical examination [45, 46, 55-61].